Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice

Inflammatory bowel disease pathogenesis

(2012) Michael Scharl et al.   CURRENT OPINION IN GASTROENTEROLOGY

Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease

(2012) Ali Raza et al.   Expert Review of Clinical Immunology

Gut Microbiota, Probiotics and Inflammatory Bowel Disease

(2011) Johannes Stephani et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10−/− mice

(2011) Udai P. Singh et al.   BRAIN BEHAVIOR AND IMMUNITY

When T Cells Run Out of Breath: The HIF-1α Story

(2011) Katherine Nutsch et al.   CELL

Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease

(2011) Lulu Sun et al.   CURRENT OPINION IN GASTROENTEROLOGY

Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease

(2011) Gheorghe Hundorfean et al.   INFLAMMATORY BOWEL DISEASES

Treatment of Mice with Dextran Sulfate Sodium-Induced Colitis with Human Interleukin 10 Secreted by TransformedBifidobacterium longum

(2011) Jun Yao et al.   MOLECULAR PHARMACEUTICS

Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture

(2010) Valerie Trapp et al.   ANGIOGENESIS

Anti-oxidant Effects of Resveratrol on Mice with DSS-induced Ulcerative Colitis

(2010) Jun Yao et al.   ARCHIVES OF MEDICAL RESEARCH

CD4+CD25+ Regulatory T Cells Suppress Th17-Responses in an Experimental Colitis Model

(2010) Haruei Ogino et al.   DIGESTIVE DISEASES AND SCIENCES

Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts

(2010) Wen-Pei Tseng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients

(2009) Andrzej Szkaradkiewicz et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination

(2009) Joo Eun Jung et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Interleukin-23/Th17 pathways and inflammatory bowel disease

(2009) Clara Abraham et al.   INFLAMMATORY BOWEL DISEASES

Importance of mucosal healing in ulcerative colitis

(2009) Gary R. Lichtenstein et al.   INFLAMMATORY BOWEL DISEASES

Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease

(2009) Nicola Eastaff-Leung et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Balance of Th1 and Th17 effector and peripheral regulatory T cells

(2009) Jens Lohr et al.   MICROBES AND INFECTION

The gut feeling of Treg cells: IL-10 is the silver lining during colitis

(2009) Derya Unutmaz et al.   NATURE IMMUNOLOGY

Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis

(2009) K. Nistala et al.   RHEUMATOLOGY

Potential role of Th17 cells in the pathogenesis ofinflammatory bowel disease

(2009) Zhan-Ju Liu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Successful treatment of a patient with takayasu arteritis using a humanized anti-interleukin-6 receptor antibody

(2008) Norihiro Nishimoto et al.   ARTHRITIS AND RHEUMATISM

Is the Th1/Th2 paradigm of immune regulation applicable to IBD?

(2008) Ivan J. Fuss   INFLAMMATORY BOWEL DISEASES

Immune Homeostasis: Regulatory T Cells (Treg) and Molecules

(2008) Sudhir Gupta   JOURNAL OF CLINICAL IMMUNOLOGY

Interplay Between Effector Th17 and Regulatory T Cells

(2008) Amit Awasthi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease

(2007) Rebecca Carey et al.   INFLAMMATORY BOWEL DISEASES